Literature DB >> 15562414

Selective loss of regulatory T cells in thymomas.

Philipp Ströbel1, Andreas Rosenwald, Niklas Beyersdorf, Thomas Kerkau, Olaf Elert, Astrid Murumägi, Niko Sillanpää, Pärt Peterson, Vera Hummel, Peter Rieckmann, Christof Burek, Berthold Schalke, Wilfred Nix, Reinhard Kiefer, Hans Konrad Müller-Hermelink, Alexander Marx.   

Abstract

Myasthenia gravis (MG) is the prime autoimmune manifestation of thymomas. We investigated the generation of T cells with a regulatory phenotype (T(R)) in thymomas with and without associated MG. In patients with MG(+) thymomas, maturation and export of T(R) cells but not of other T-cell subsets was significantly reduced. We conclude that imbalance between effector and regulatory T cells in thymomas may be involved in modulation of onset and/or severity of MG.

Entities:  

Mesh:

Year:  2004        PMID: 15562414     DOI: 10.1002/ana.20340

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

Review 1.  Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.

Authors:  Yoshihisa Kadota; Hirotoshi Horio; Takeshi Mori; Noriyoshi Sawabata; Taichiro Goto; Shin-ichi Yamashita; Takeshi Nagayasu; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-01-22

2.  A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.

Authors:  Anish Thomas; Arun Rajan; Eva Szabo; Yusuke Tomita; Corey A Carter; Barbara Scepura; Ariel Lopez-Chavez; Min-Jung Lee; Christophe E Redon; Ari Frosch; Cody J Peer; Yuanbin Chen; Richard Piekarz; Seth M Steinberg; Jane B Trepel; William D Figg; David S Schrump; Giuseppe Giaccone
Journal:  Clin Cancer Res       Date:  2014-09-04       Impact factor: 12.531

3.  Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis.

Authors:  Kimitoshi Kimura; Yoichiro Okada; Chihiro Fujii; Kenichi Komatsu; Ryosuke Takahashi; Sadayuki Matsumoto; Takayuki Kondo
Journal:  J Neurol       Date:  2019-07-24       Impact factor: 4.849

4.  Paraneoplastic diseases associated with thymoma.

Authors:  Amelia Evoli; Giacomo Maria Minicuci; Roberta Vitaliani; Alessandra Battaglia; Giacomo Della Marca; Libero Lauriola; Andrea Fattorossi
Journal:  J Neurol       Date:  2007-02-26       Impact factor: 4.849

Review 5.  Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Expert Rev Clin Immunol       Date:  2012-07       Impact factor: 4.473

6.  Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.

Authors:  Andrea Fattorossi; Alessandra Battaglia; Alexia Buzzonetti; Giacomo Minicuci; Raffaella Riso; Laura Peri; Giovanni Scambia; Amelia Evoli
Journal:  J Clin Immunol       Date:  2007-11-14       Impact factor: 8.317

7.  Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas.

Authors:  S Scarpino; A Di Napoli; A Stoppacciaro; M Antonelli; E Pilozzi; R Chiarle; G Palestro; M Marino; F Facciolo; E A Rendina; K E Webster; S A Kinkel; H S Scott; L Ruco
Journal:  Clin Exp Immunol       Date:  2007-06-22       Impact factor: 4.330

Review 8.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

9.  Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database.

Authors:  Sukhmani K Padda; Xiaopan Yao; Alberto Antonicelli; Jonathan W Riess; Yue Shang; Joseph B Shrager; Robert Korst; Frank Detterbeck; James Huang; Bryan M Burt; Heather A Wakelee; Sunil S Badve
Journal:  J Thorac Oncol       Date:  2017-11-27       Impact factor: 15.609

10.  Risk factors for tumor occurrence in patients with myasthenia gravis.

Authors:  Antonietta Citterio; Ettore Beghi; Andrea Millul; Amelia Evoli; Renato Mantegazza; Carlo Antozzi; Fulvio Baggi; Ferdinando Cornelio; Luca Durelli; Marinella Clerico; Giovanni Piccolo; Vittorio Cosi
Journal:  J Neurol       Date:  2009-03-29       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.